- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07686705
Intravenous Versus Intra-articular Tranexamic Acid for Visual Clarity During Arthroscopic Rotator Cuff Repair
The Effect of Intravenous Versus Intra-articular Tranexamic Acid on Visual Clarity During Arthroscopic Rotator Cuff Repair: A Prospective, Randomized, Double-blind Controlled Trial
This single-center, prospective, randomized, double-blind controlled trial evaluated whether intravenous (IV) or intra-articular (IA) administration of tranexamic acid (TXA) improves intraoperative visual clarity, compared with a no-TXA control, during arthroscopic rotator cuff repair. Patients with rotator cuff tears were randomly allocated to one of three groups: a control group receiving no TXA; an IA group in which 500 mg of TXA was added to each 1 L of normal-saline irrigation fluid; and an IV group receiving 1000 mg of TXA intravenously 10 minutes before surgery. The operating surgeon graded visual clarity on a 0-10 numeric scale at the end of each of six predefined surgical stages. Secondary outcomes included total operative time, estimated blood loss, irrigation-fluid volume, the number of irrigation-pressure increases, postoperative shoulder swelling, and postoperative day 1 pain.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Seoul
-
Seoul, Seoul, Südkorea, 05030
- Konkuk University Medical Center
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age 18-80 years
- Diagnosed with a rotator cuff tear
- Failure of conservative treatment for more than 3 months
- Rotator cuff deemed repairable on magnetic resonance imaging
Exclusion Criteria:
- Known hypersensitivity to tranexamic acid
- Previous cerebrovascular accident
- Coronary stent or other history of thromboembolic disease
- Anticoagulant therapy
- Uncontrolled hypertension (systolic pressure > 180 mmHg)
- Abnormal prothrombin time or activated partial thromboplastin time
- Acute traumatic rotator cuff tear
- Irreparable rotator cuff tear
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Kein Eingriff: Control
No tranexamic acid; arthroscopic rotator cuff repair performed with plain normal-saline irrigation. |
|
|
Experimental: Intra-articular TXA
Tranexamic acid 500 mg added to each 1 L of normal-saline irrigation fluid during arthroscopic rotator cuff repair. |
500 mg of tranexamic acid added per 1 L of normal-saline irrigation fluid. |
|
Experimental: Intravenous TXA
Tranexamic acid 1000 mg administered intravenously 10 minutes before surgery; plain normal-saline irrigation as in the control group. |
1000 mg of tranexamic acid administered intravenously 10 minutes before surgery. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Intraoperative visual clarity
Zeitfenster: Intraoperatively, at the end of each of the six surgical stages
|
Surgeon-rated clarity of the arthroscopic surgical field on a 0-10 numeric scale (0 = poorest visualization, 10 = optimal visualization), scored at the end of each of six surgical stages: glenohumeral procedure, subacromial bursectomy, acromioplasty, rotator cuff inspection, medial-row repair, and lateral-row repair. |
Intraoperatively, at the end of each of the six surgical stages
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Total operative time
Zeitfenster: Intraoperative (duration of surgery)
|
Total duration of the surgical procedure. |
Intraoperative (duration of surgery)
|
|
Estimated blood loss
Zeitfenster: postoperative day 1
|
Estimated blood loss calculated from serum hemoglobin measured before and after surgery using the formula described by Good et al. |
postoperative day 1
|
|
Irrigation-fluid volume
Zeitfenster: Intraoperatively, from skin incision to skin closure (duration of surgery)
|
Total volume of irrigation fluid used during the procedure. |
Intraoperatively, from skin incision to skin closure (duration of surgery)
|
|
Number of irrigation-pressure increases
Zeitfenster: Intraoperatively, from skin incision to skin closure (duration of surgery)
|
Number of times the irrigation pump pressure was increased to control bleeding affecting the surgical field |
Intraoperatively, from skin incision to skin closure (duration of surgery)
|
|
Postoperative shoulder swelling
Zeitfenster: Baseline (pre-operative) and postoperative day 1
|
Shoulder circumference and diameter measured at the axillary and deltoid sites with the arm abducted ~30 degrees, compared between pre-operative and postoperative day 1 |
Baseline (pre-operative) and postoperative day 1
|
|
Postoperative pain
Zeitfenster: Pain assessed using the Visual Analog Scale (VAS) for pain, ranging from 0 (no pain) to 10 (worst imaginable pain); higher scores indicate worse outcome, on postoperative day 1
|
Pain assessed using a visual analog scale (VAS) on postoperative day 1 |
Pain assessed using the Visual Analog Scale (VAS) for pain, ranging from 0 (no pain) to 10 (worst imaginable pain); higher scores indicate worse outcome, on postoperative day 1
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Seok Won Chung, MD, Konkuk University Medical Center
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2022-12-017
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
There is no plan to share individual participant data.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .